Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 26:14:1225909.
doi: 10.3389/fphar.2023.1225909. eCollection 2023.

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology

Yoshihiro Noguchi  1 , Miao Yan  2   3   4 , Satoshi Yokoyama  5 , Elisabetta Poluzzi  6
Affiliations
Editorial

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology

Yoshihiro Noguchi et al. Front Pharmacol. .
No abstract available

Keywords: adverse events; drug repositioning; drug-drug interactions (DDI); pharmacoepidemiology; pharmacovigilance; synergy pharmaceutical science.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Pharmacovigilance and drug repositioning research using pharmacoepidemiology

References

    1. Fusaroli M., Isgrò V., Cutroneo P. M., Ferrajolo C., Cirillo V., Del Bufalo F., et al. (2022). Post-marketing surveillance of CAR-T-cell therapies: Analysis of the FDA adverse event reporting system (FAERS) database. Drug Saf. 45, 891–908. 10.1007/s40264-022-01194-z - DOI - PMC - PubMed
    1. Kinoshita S., Hosomi K., Yokoyama S., Takada M. (2020). Inverse association between metformin and amiodarone-associated extracardiac adverse events. Int. J. Med. Sci. 17, 302–309. 10.7150/ijms.39342 - DOI - PMC - PubMed
    1. Lin L. Y., Warren-Gash C., Smeeth L., Chen P. C. (2018). Data resource profile: The national health insurance research database (NHIRD). Epidemiol. Health 40, e2018062. 10.4178/epih.e2018062 - DOI - PMC - PubMed
    1. Noguchi Y., Tachi T., Teramachi H. (2021). Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief. Bioinform 22, bbab347. 10.1093/bib/bbab347 - DOI - PubMed
    1. van De Ven N. S., Pozniak A. L., Levi J. A., Clayden P., Garratt A., Redd C., et al. (2020). Analysis of pharmacovigilance databases for dolutegravir safety in pregnancy. Clin. Infect. Dis. 70, 2599–2606. 10.1093/cid/ciz684 - DOI - PubMed

Publication types

LinkOut - more resources